Description

This is SMi`s fifth conference on the subject of RNAi, siRNA and miRNA 2010. It will build on the success of the past four years, and brings together the leading experts in industry and academia to explore the cutting edge of new therapeutics being researched and brought to the marketplace.
This conference will look at a wide range of issues within the RNAi arena. It will combine a study of the latest successes in the research and development phase with presentations covering the key themes of delivery, target identification and IP issues.

There will be keynote presentations on:

Nanomedicinal siRNA delivery technologies and pulmonary siRNA delivery systems
The promise and challenges of therapeutic siRNA for the treatment of respiratory disease
Target identification and progression utilising siRNA libraries in physiological primary immune cell assays
Pharmaceutical development of a novel systemic oligonucleotide delivery formulation
Immunology of nucleic acids

Hear Senior Representatives from:

Novartis
GlaxoSmithKline
Pfizer
Sylentis
ValiRx
Medesis Pharma
And more

Sponsorship and Exhibition Opportunities are available
To find out more contact Alia Malick - Head of Pharmaceuticals
On tel: +44 (0)20 7827 6168 or email: amalick@smi-online.co.uk